Testosterone Lawsuit News: Androgel Lawsuit Conference Held

Lawyers handling for the Onder Law Firm provide a testosterone lawsuit news update, reporting on a recent case management conference in the multidistrict litigation Testosterone Replacement Therapy Products Liability Litigation.

Friday, July 31, 2015 - In the most recent testosterone lawsuit news related to the multidistrict litigation* currently underway in U.S. District Court in the Northern District of Illinois, Androgel testosterone attorneys report that a "Mini Status Conference" was held recently, according to court documents. On Monday, July 20, a docket entry was made recording the minutes of the status conference, which was held that day, according to court documents. While the agenda of the conference were not made public, the judge, the Honorable Matthew F. Kennelly, did report that all items on the agenda were addressed.

"The recent topic under consideration in the testosterone lawsuit multidistrict litigation is the establishment of bellwether cases. These are cases that are carefully chosen as representative of the larger group of lawsuits. These particular cases will be tried in the near future, and establish a precedent for resolving the bulk of the testosterone lawsuits," explained a representative of the Onder Law Firm.

"The testosterone lawsuit multidistrict litigation is more complex than some others because there are a large number of defendants, which include pharmaceutical companies who market a range of testosterone replacement therapy products. The court has decided that bellwether trials will be limited to a narrow field, selected only from among cases filed against the pharmaceutical company AbbVie, and related only to allegations of heart attack, stroke, or another cardiac problem in a patient who took Androgel. The court is still in the process of selecting bellwether cases from among those that meet the qualifications. The complicate matters further, new testosterone lawsuits are still be accepted to join the multidistrict litigation," the testosterone attorney from the Onder Law Firm says.

When testosterone lawsuits were first proposed for consolidation as a multidistrict litigation, the cases included only those related to Androgel and AbbVie, according to court documents. However, the MDL was soon expanded to include similar allegations against a number of different companies for drugs such as Testim, Androderm, and others, and a new name for the MDL was adopted to reflect the wider reach of the litigation: Testosterone Replacement Therapy Products Liability Litigation, according to court documents.

Each of the testosterone lawsuits consolidated in the MDL shares common questions of fact - namely that the plaintiffs or their loved one allegedly suffered from a stroke, heart attack, or other serious injury as a result of taking Androgel or another testosterone drug, according to court documents. In the initial Complaint, an official court document, plaintiffs allege they were not adequately warned of the risks associated with testosterone replacement therapy, and furthermore, that drug company advertising led to self-diagnosis "Low-T". In reality, testosterone replacement therapy has only been approved by the FDA to treat men who suffer from verifiable hypogonadism - a condition that can only be diagnosed through a blood test, that is distinguished by the absence of serum testosterone in the body, and that can result in other harmful health conditions, according to court documents.

These testosterone lawyers provide timely Androgel lawsuit news updates and testosterone side effects research at their website, the Androgel Testosterone Lawsuit Center. The firm is nationally renowned for its representation of American families and individuals against major corporations through pharmaceutical, product liability, and personal injury lawsuits. Persons who believe they may have grounds to file a testosterone lawsuit alleging heart attack or stroke may contact the firm for a free case review through the website.

Lawyers handling testosterone lawsuit claims for the Onder Law Firm believe qualifying persons may be entitled to real compensation and offer no-cost, no-obligation case review to persons or family members of those who have suffered heart attack, stroke, or another serious health problem possibly related to Androgel or another testosterone product.

The Onder Law Firm welcomes testosterone lawsuit inquiries from law firms in regards to handling them or working as co-counsel.

About The Onder Law Firm

Onder, Shelton, O‘Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The pharmaceutical and medical device litigators at The Onder Law Firm have represented thousands of Americans in lawsuits against multinational conglomerates from products liability for manufacture of defective or dangerous products to deceptive advertising practices. Other firms throughout the nation often seek its experience and expertise on complex litigation. It is also a recognized leader in products liability cases such as window blind cord strangulation. The Onder Law Firm offers information from attorneys handling testosterone lawsuits at http://www.AndrogelTestosteroneLawsuitCenter.com.

*Testosterone Replacement Therapy Products Liability Litigation, MDL 2545, U.S. District Court, Northern District of Illinois

Other Testosterone Drugs Lawsuit Attorney News Releases: